Cardio Diagnostics (CDIO) Launches Revolutionary Blood Test for Early Detection of Coronary Heart Disease

Go back to Cardio Diagnostics (CDIO) Launches Revolutionary Blood Test for Early Detection of Coronary Heart Disease

Cardio Diagnostics Holdings Inc Launches Revolutionary Blood Test for Early Detection of Coronary Heart Disease

February 28, 2023 8:00 AM EST

PrecisionCHD is the First Integrated Epigenetic-Genetic-Based Blood Test for the Early Detection of Coronary Heart Disease

CHICAGO--(BUSINESS WIRE)-- Cardio Diagnostics Holdings Inc (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced the launch of PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart... More